Outcome | ALL | CON | EXE | MOT | P-value |
---|---|---|---|---|---|
Number of participants | n = 178 | n = 34 | n = 74 | n = 70 |  |
Pregnancy complications | |||||
GDM, n (%) | 12 (7%) | 2 (6%) | 5 (7%) | 5 (7%) | 1.000a |
Gestational hypertensive disorders, n (%)* | 11 (6%) | 2 (6%) | 4 (5%) | 5 (7%) | 0.919a |
Delivery related outcomes | |||||
Induction of labor, n (%) | 53 (30%) | 11 (32%) | 22 (30%) | 20 (29%) | 0.925a |
Mode of delivery, n (%) | |||||
 Unassisted vaginal | 138 (78%) | 30 (88%) | 60 (81%) | 48 (69%) | 0.050a |
 Instrumental assisted vaginal | 8 (5%) | 1 (3%) | 1 (1%) | 6 (9%) | 0.103a |
 Planned caesarean section | 11 (6%) | 1 (3%) | 5 (7%) | 5 (7%) | 0.791a |
 Emergency caesarean section | 21 (12%) | 2 (6%) | 8 (11%) | 11 (16%) | 0.333a |
Epidural analgesia, n (%) | 58 (33%) | 9 (27%) | 25 (34%) | 24 (34%) | 0.698a |
Oxytocin augmentation, n (%) | 46 (26%) | 5 (15%) | 24 (32%) | 17 (24%) | 0.138a |
Rupture degree 3 + 4, n (%)** | 8 (5%) | 1 (3%) | 3 (4%) | 4 (6%) | 0.805a |
Postpartum haemorrhage, ml | 350 (250–508) | 300 (200–445) | 350 (250–593) | 400 (250–540) | 0.212b |
Postpartum haemorrhage > 1000 ml, n (%) | 19 (11%) | 2 (6%) | 11 (15%) | 6 (9%) | 0.300a |
Duration of labor nulliparous | |||||
 Total duration vaginal delivery, min** | 443 (273–617) | 523 (199–582) | 481 (363–678) | 298 (198–488) | 0.163b |
 Duration of active second stage labor, min** | 41 (22–65) | 53 (16–70) | 43 (23–67) | 34 (21–44) | 0.436b |
 Active second stage labor > 60 min, n (%)** | 15 (27%) | 3 (27%) | 9 (31%) | 3 (20%) | 0.797a |
Duration of labor multiparous | |||||
 Total duration vaginal delivery, min** | 150 (86–262) | 126 (102–254) | 152 (79–277) | 160 (88–262) | 0.994b |
 Duration of active second stage labor, min** | 13 (7–19) | 13 (6–20) | 14 (7–19) | 11 (6–19) | 0.849b |
 Active second stage labor > 30 min, n (%)** | 11 (13%) | 3 (16%) | 2 (7%) | 6 (16%) | 0.592a |